Samsung Biologics

207940.KO

661.07 USD

-6.40

-0.96%

Overview

Last close

661.07 usd

Market cap

30.60B usd

52 week high

761.21 usd

52 week low

634.23 usd

Target price

661.07 usd

Valuation

P/E

N/A

Forward P/E

70.922

Price/Sales

15.471

Price/Book Value

9.9464

Enterprise Value

48.62B usd

EV/Revenue

16.1409

EV/EBITDA

26.4445

Key financials

Revenue TTM

3.01B usd

Gross Profit TTM

1.66B usd

EBITDA TTM

1.78B usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

7.67B usd

Net debt

533.63M usd

About

Samsung Biologics Co.,Ltd., together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally. Its development services include late discovery, cell line development, process development, analytical development, and non-GMP / CGMP manufacturing. The company also offers aseptic filling, lyophilization, finishing, cold chain storage and shipping, and regulatory support services; and quality services and analytical testing services, such as IPC and release testing, stability study and testing, environmental monitoring, biosafety testing, as well as manufactures drug substance. In addition, it engages in the development and manufacture of antibody-drug conjugates and mRNA products. The company was founded in 2011 and is headquartered in Incheon, South Korea.